Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
72
GOSS Quote, Financials, Valuation and Earnings
Last price:
$1.72
Seasonality move
:
3.89%
Day range:
$1.64 - $1.80
52-week range:
$0.66 - $1.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.06x
P/B ratio:
8.01x
Volume:
4.2M
Avg. volume:
2.5M
1-year change:
56.88%
Market cap:
$377.3M
Revenue:
$114.7M
EPS (TTM):
-$0.23
Earnings Data
Next earnings date for GOSS
Aug 12
2025
Most recent earnings per share
-$0.16
Beat by $0.03
(May 15/2025)
Consensus Estimate
-$0.19
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GOSS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $5.2M | -- | -- | -$0.18 | -- |
| 08/12/2025 | Q2 | $4.7M | -- | -- | -$0.18 | -- |
| 05/15/2025 | Q1 | $3.9M | $9.9M | -$0.16 | -$0.19 | $0.03 |
| 03/13/2025 | Q4 | $6.8M | $9.4M | -$0.15 | -$0.17 | $0.02 |
| 11/07/2024 | Q3 | $7.6M | $9.5M | -$0.14 | -$0.14 | $0.00 |
| 08/12/2024 | Q2 | $100M | $95.8M | $0.22 | $0.27 | -$0.05 |
| 05/07/2024 | Q1 | -- | -- | -$0.19 | -$0.19 | $0.00 |
| 03/05/2024 | Q4 | -- | -- | -$0.15 | -$0.21 | $0.06 |
| 11/09/2023 | Q3 | -- | -- | -$0.21 | -$0.27 | $0.06 |
| 08/08/2023 | Q2 | -- | -- | -$0.45 | -$0.50 | $0.05 |
| 05/09/2023 | Q1 | -- | -- | -$0.52 | -$0.54 | $0.02 |
| 03/17/2023 | Q4 | -- | -- | -$0.59 | -$0.63 | $0.04 |
| 11/03/2022 | Q3 | -- | -- | -$0.65 | -$0.66 | $0.01 |
| 08/09/2022 | Q2 | -- | -- | -$0.74 | -$0.69 | -$0.05 |
| 05/10/2022 | Q1 | -- | -- | -$0.76 | -$0.76 | -$0.00 |
| 03/03/2022 | Q4 | -- | -- | -$0.74 | -$0.78 | $0.04 |
| 11/08/2021 | Q3 | -- | -- | -$0.80 | -$0.77 | -$0.03 |
| 08/09/2021 | Q2 | -- | -- | -$0.80 | -$0.76 | -$0.04 |
| 05/06/2021 | Q1 | -- | -- | -$0.78 | -$0.74 | -$0.04 |
| 02/25/2021 | Q4 | -- | -- | -$0.88 | -$0.79 | -$0.09 |
| 11/10/2020 | Q3 | -- | -- | -$0.80 | -$0.85 | $0.05 |
| 08/11/2020 | Q2 | -- | -- | -$1.00 | -$0.86 | -$0.14 |
| 05/12/2020 | Q1 | -- | -- | -$0.87 | -$0.76 | -$0.12 |
| 03/24/2020 | Q4 | -- | -- | -$0.89 | -$0.86 | -$0.03 |
| 11/12/2019 | Q3 | -- | -- | -$0.80 | -$0.68 | -$0.12 |
| 08/08/2019 | Q2 | -- | -- | -$0.74 | -$0.43 | -$0.31 |
| 05/14/2019 | Q1 | -- | -- | -$0.90 | -$0.58 | -$0.32 |
| 03/22/2019 | Q4 | -- | -- | -$1.39 | -$1.41 | $0.02 |
Gossamer Bio Earnings Questions
-
How Much did Gossamer Bio Generate in Revenue Last Quarter?
Gossamer Bio reported $9.9M worth of top line sales in its most recent quarter.
-
Did Gossamer Bio Beat Earnings Last Quarter?
Gossamer Bio announced earnings per share of -$0.16 which represents a beat of analyst forecast a -$0.19 per share.
-
Is Gossamer Bio Profitable?
Gossamer Bio reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Gossamer Bio EPS Next Year?
Gossamer Bio's earnings are forecast to decrease from -$0.25 per share to -$0.28 per share next year representing a decrease of -177.27%.
-
When is Gossamer Bio's Earnings Date?
Gossamer Bio's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
